Analyst Ratings For NYSE:BSX – Boston Scientific (NYSE:BSX)
Today, Citigroup raised its price target on NYSE:BSX – Boston Scientific (NYSE:BSX) to $34.00 per share.
Some recent analyst ratings include
- 4/26/2018-Jefferies Group Reiterated Rating of Hold.
- 4/25/2018-Canaccord Genuity Reiterated Rating of Buy.
Recent Insider Trading Activity For NYSE:BSX – Boston Scientific (NYSE:BSX)
NYSE:BSX – Boston Scientific (NYSE:BSX) has insider ownership of 0.73% and institutional ownership of 90.98%.
- On 4/2/2018 David A Pierce, EVP, sold 5,000 with an average share price of $27.22 per share and the total transaction amounting to $136,100.00.
- On 3/20/2018 John Bradley Sorenson, SVP, sold 2,200 with an average share price of $27.63 per share and the total transaction amounting to $60,786.00.
- On 3/19/2018 Daniel J Brennan, CFO, sold 60,209 with an average share price of $27.87 per share and the total transaction amounting to $1,678,024.83.
- On 3/14/2018 Kevin J Ballinger, EVP, sold 42,803 with an average share price of $28.32 per share and the total transaction amounting to $1,212,180.96.
- On 3/5/2018 John Bradley Sorenson, SVP, sold 1,950 with an average share price of $27.43 per share and the total transaction amounting to $53,488.50.
- On 2/28/2018 David A Pierce, SVP, sold 4,508 with an average share price of $27.54 per share and the total transaction amounting to $124,150.32.
- On 2/21/2018 David A Pierce, SVP, sold 16,286 with an average share price of $27.00 per share and the total transaction amounting to $439,722.00.
Recent Trading Activity for NYSE:BSX – Boston Scientific (NYSE:BSX)
Shares of NYSE:BSX – Boston Scientific closed the previous trading session at 29.31 up +0.58 2.02% with 28.709999084472656 shares trading hands.